|Bid||131.83 x 800|
|Ask||133.50 x 1200|
|Day's Range||127.33 - 134.59|
|52 Week Range||45.47 - 161.71|
|Beta (5Y Monthly)||0.99|
|PE Ratio (TTM)||596.74|
|Earnings Date||Aug 03, 2021 - Aug 09, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||138.00|
Growth stocks might grab headlines and excite the market, but sometimes they end up deflating just as quickly as they climbed. In contrast, value stocks are perfect for cautious investors because they tend to have business models that have stood the test of time. Since the start of the pandemic, Retractable Technologies (NYSEMKT: RVP) has been on a tear.
STAAR Surgical (STAA) has been struggling lately, but the selling pressure may be coming to an end soon.
LAKE FOREST, Calif., July 21, 2021--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results for the second quarter ended July 2, 2021 on Wednesday, August 4, 2021 after the market close.